Marijuana for medical purposes
Dr. Mark Ware, director of clinical research, Alan Edwards Pain Management Unit, McGill University Health Centre
Dr. Mark Nixon, patient interviewee
Dr. Trevor Theman, Registrar, College of Physicians and Surgeons of Alberta
With changes in regulations for the prescription of marijuana for medical purposes and the impact this has on the physician’s role, this session aims to increase overall understanding and the physician’s comfort level in discussing the topic with patients who request a medical marijuana prescription.
- increase their knowledge on regulation/licensure issues and considerations related to prescribing medical marijuana
- identify pertinent issues as they pertain to both patient and physician perspectives
- recognize obstacles/challenges and opportunities in prescribing medical marijuana for medical purposes
- convey opinions/support that may form the basis of further CMA policy work in this area
This event is an Accredited Learning activity (Section 1) as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada for 16.5. This program has been reviewed and approved by the University of Ottawa, Office of Continuing Professional Development.
This program has been accredited by the College of Family Physicians of Canada and the Ontario Chapter for up to 16 Mainpro-M1 credits.